000 05296nam a22006255i 4500
001 978-981-97-4909-6
003 DE-He213
005 20250516160158.0
007 cr nn 008mamaa
008 241122s2024 si | s |||| 0|eng d
020 _a9789819749096
_9978-981-97-4909-6
050 4 _aQR
072 7 _aPSG
_2bicssc
072 7 _aSCI045000
_2bisacsh
072 7 _aPSG
_2thema
082 0 4 _a579
_223
245 1 0 _aRecent Advances in Human Fungal Diseases
_h[electronic resource] :
_bProgress and Prospects /
_cedited by Saif Hameed, Pooja Vijayaraghavan.
250 _a1st ed. 2024.
264 1 _aSingapore :
_bSpringer Nature Singapore :
_bImprint: Springer,
_c2024.
300 _aXVI, 475 p. 578 illus., 491 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPart I. Candida and candidiasis -- Chapter 1. Diagnosis of candida and candidiasis: current methods and future challenges -- Chapter 2. Fungal fighters: a comprehensive guide to antifungal therapies of the past, present and future -- Chapter 3. Candidiasis treatment: an evolutionary journey from past to present and a glimse into the future -- Chapter 4. MDR in candida: the real storm -- Chapter 5. Surviving the storm: how candida species master adaptation for pathogenesis -- Chapter 6. Molecular cues and mechanisms of pathogenesis in candida -- Chapter 7. Factors affecting drug resistance and virulence in fungal pathogen -- Chapter 8. Unravelling drug resistance in candida species: genetic, biofilm, transcriptional and epigenetic perspectives -- Chapter 9. Biofilm formation in candida species -- Chapter 10. Candida auris biofilm: a medical ambrosia -- Chapter 11. Candida albicans mixed species biofilms and associated antimicrobial resistance -- Chapter 12. Decoding the complex terrain of candida tropicalis induced candidiasis: insights into epidemology, infection mechanisms, theraputics and drug resistance -- Chapter 13. Candiasis drug resistance and translational research -- Part II. Aspergillus and aspergillosis -- Chapter 14. Therapeutic strategies and challenges in the management of aspergillus infections -- Chapter 15. Aspergillus therapeutics: future agents -- Chapter 16. Recent advances in the management of aspergillosis -- Chapter 17. Drug resistance patterns in opportunistic aspergilli: a molecular perspective -- Chapter 18. A comprehensive and intricate dynamics of aspergillus: implications, therapeutic challenges, and drug resistance -- Chapter 19. Understanding molecular pathogenesis of aspergillus fumigatus.
520 _aThe book explores Candida and candidiasis, and Aspergillus and aspergillosis, two significant fungal infectious diseases. In the first section, various aspects of Candida infection are covered. The book delves into the epidemiology of Candida infections, highlighting their prevalence and distribution. It thoroughly discusses diagnostics and pathogenesis of candidiasis, providing valuable insights into the identification, and understanding of the disease. Additionally, the book addresses the growing concern of drug resistance and provides an overview of current therapeutics for candidiasis. Chapters in the second section examine the epidemiology of Aspergillus infections, providing a comprehensive understanding of their occurrence and impact. It discusses the diagnostics and pathogenesis of aspergillosis, shedding light on the methods for accurate diagnosis and the mechanisms by which the infection develops. It explores the host-pathogen interaction and the role of biofilms in these infections. Furthermore, the book addresses the pressing issue of drug resistance in aspergillosis and presents an overview of therapeutic approaches available for managing the disease. This book serves as a valuable resource for researchers, clinicians, and healthcare professionals seeking in-depth knowledge of these fungal infectious diseases.
541 _fUABC ;
_cPerpetuidad
650 0 _aMicrobiology.
650 0 _aFungi.
650 0 _aMycology.
650 0 _aBiology.
650 0 _aOncogenic viruses.
650 0 _aDrug delivery systems.
650 0 _aPharmacovigilance.
650 1 4 _aMicrobiology.
650 2 4 _aFungi.
650 2 4 _aBiological Sciences.
650 2 4 _aTumour Virus Infections.
650 2 4 _aDrug Delivery.
650 2 4 _aDrug Safety and Pharmacovigilance.
700 1 _aHameed, Saif.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aVijayaraghavan, Pooja.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9789819749089
776 0 8 _iPrinted edition:
_z9789819749102
776 0 8 _iPrinted edition:
_z9789819749119
856 4 0 _zLibro electrónico
_uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-981-97-4909-6
912 _aZDB-2-SBL
912 _aZDB-2-SXB
942 _cLIBRO_ELEC
999 _c276859
_d276858